RNWL
INTERNATIONAL REGISTRATION RENEWED
06/10/2025
Back to search
Official data from USPTO
DROSSAPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
06/11/2025
Trademark type
Combined
Nice classes
5
Filing date
05/26/2016
Registration date
03/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/22/2023
Last transaction
06/11/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
25
Owner location
BASEL, CH
Examiner
NADELMAN, ANDREA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Drossapharm AG
Representatives
Richard M. Goldberg Goldberg Patent Law Office
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Proprietary medicines in the nature of pharmaceutical preparations for the treatment of skin and scalp diseases and disorderspharmaceutical preparations for the treatment of mouth diseasespharmaceutical preparations for the treatment of rheumatic diseasespharmaceutical preparations for the treatment of the musculoskeletal systempharmaceutical preparations for the treatment of the cardio-vascular system
Publications
History of USPTO decisions and trademark events.
30 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/20/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/27/2024
INPC
INVALIDATION PROCESSED
06/27/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/14/2024
C71T
CANCELLED SECTION 71
09/22/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/07/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/11/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/20/2017
FIMP
FINAL DISPOSITION PROCESSED
06/20/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/07/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2016
PUBO
PUBLISHED FOR OPPOSITION
12/20/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/14/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/31/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/31/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/31/2016
ALIE
ASSIGNED TO LIE
10/25/2016
RFNT
REFUSAL PROCESSED BY IB
10/21/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/22/2016
RFRR
REFUSAL PROCESSED BY MPU
09/22/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/21/2016
CNRT
NON-FINAL ACTION WRITTEN
09/20/2016
MAFR
APPLICATION FILING RECEIPT MAILED
09/20/2016
DOCK
ASSIGNED TO EXAMINER
09/15/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2016
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
09/08/2016
Continuous trademark protection
Get notified about every new filing that threatens DROSSAPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.